KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Sales (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Return on Sales for 16 consecutive years, with 1291.68% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 112486.0% to 1291.68% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1291.68% through Dec 2025, down 79658.0% year-over-year, with the annual reading at 1291.68% for FY2025, 79658.0% down from the prior year.
  • Return on Sales hit 1291.68% in Q4 2025 for Inovio Pharmaceuticals, down from 476.54% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 4.13% in Q3 2022 to a low of 1291.68% in Q4 2025.
  • Historically, Return on Sales has averaged 322.41% across 5 years, with a median of 272.33% in 2023.
  • Biggest five-year swings in Return on Sales: soared 20214bps in 2022 and later plummeted -112486bps in 2025.
  • Year by year, Return on Sales stood at 127.45% in 2021, then crashed by -243bps to 436.87% in 2022, then surged by 44bps to 243.58% in 2023, then skyrocketed by 32bps to 166.82% in 2024, then plummeted by -674bps to 1291.68% in 2025.
  • Business Quant data shows Return on Sales for INO at 1291.68% in Q4 2025, 476.54% in Q3 2025, and 507.16% in Q2 2025.